Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.

Postgraduate medicine - 1 Jul 2010

Arai Ronen

Abstract excerpt

Inflammatory bowel disease (IBD) is difficult to diagnose, and differentiating between ulcerative colitis (UC) and Crohn's disease (CD) can be challenging. Overlapping symptoms of UC and CD often delay diagnosis, despite availability of endoscopic, radiologic, and histologic tools. This delay in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Disease Progression
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Diagnosis

Share to Inflammatory Bowel Diseases

Share to Phenotype

Source

Identifiers

PMID: 20675980
DOI: 10.3810/pgm.2010.07.2184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20675980-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.PMID 20675980Read ↗

Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.Semantic proximity Read ↗

Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.Semantic proximity Read ↗

Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.Semantic proximity Read ↗

Molecular diagnosis and classification of inflammatory bowel disease.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.Semantic proximity Read ↗

The role of autoantibodies in inflammatory bowel disease.Semantic proximity Read ↗

Serologic antiglycan antibodies in inflammatory bowel disease.Semantic proximity Read ↗

[Relevance of serologic studies in inflammatory bowel diseases].Semantic proximity Read ↗

New serological markers in pediatric patients with inflammatory bowel disease.Semantic proximity Read ↗

[Diagnostic value of different serological markers and correlation analysis with disease phenotype in inflammatory bowel disease].Semantic proximity Read ↗

Diagnostic utility and phenotype correlation of serum ASCA and ANCA in pediatric inflammatory bowel diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.